Studies have shown that Notch2 expression is closely associated with patient prognosis and tumor cell resistance [27–29], and our analysis further revealed that high Notch2 expression is linked to poor prognosis in gastric cancer patients (Fig. S2B). This evidence concerns the gene NOTCH2 and gastric cancer.